Conmed (CNMD) Tops Q2 EPS by 7c, provides guidance

July 31, 2024 4:10 PM EDT
Get Alerts CNMD Hot Sheet
Price: $51.07 -0.6%

Financial Fact:
Net Income Basic: 0.26

Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE

Conmed (NYSE: CNMD) reported Q2 EPS of $0.98, $0.07 better than the analyst estimate of $0.91. Revenue for the quarter came in at $332.1 million versus the consensus estimate of $334.34 million.

GUIDANCE:

Conmed sees FY 2024 EPS of $3.95-$4.02, versus the consensus of $4.29. Conmed sees FY 2024 revenue of $1.305-1.315 billion, versus the consensus of $1.34 billion.

For earnings history and earnings-related data on Conmed (CNMD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK